Hoorvash Farajidana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hoorvash Farajidana has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Hossein Sanaei-Zadeh
Medical school, Shiraz University of medical Sciences, Shiraz, Iran
4 shared publications - Nasim Zamani
Department of Clinical Toxicology, Loghman-Hakim Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 shared publications - Hossein Hassanian-Moghaddam
Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications - Abdollah Amirfarhangi
Shahid Rajaee Hospital, Iran University of Medical Sciences, Tehran, Iran
1 shared publication - Babak Mostafazadeh
Toxicological Research Center, Excellence Center & Department of Clinical Toxicology, School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran
1 shared publication Hamid Owliaey
1 shared publication
Latest Publications
- Open Access
- 1 June 2013
- Published by Walter de Gruyter GmbH in Archives of Industrial Hygiene and Toxicology
- Vol. 64 (2) , 265-271
Electrocardiographic Manifestations in Acute Methanol Poisoning Cannot Predict Mortality
The aim of this retrospective observational case series was to determine electrocardiographic (ECG) manifestations in patients poisoned with methanol and see whether they could predict mortality. We also wanted to see whether there was an association between ECG changes and time elapsed between ingestion and treatment, age, sex, seizure, coma (Glasgow Coma Scale ≤8), arterial blood gas (ABG) parameters, and serum potassium levels on hospital admission. The study included 42 patients aged 31.14±12.5 years. Twenty-five survived and 17 died. Almost all patients had one or more abnormal ECG findings, including heart rate, rhythm, and conduction abnormalities. However, we found no significant difference between survivors and non-survivors. QTc interval did not correlate with time elapsed between ingestion and treatment, age, sex, seizure and coma, HCO3-, or serum potassium level. Similarly, T waves showed no correlation with serum potassium. ECG abnormalities did not correlate with coma or seizure. Even though cardiotoxicity in methanol poisoning is high, none of the ECG abnormalities found in our study predicted mortality. This however does not rule out the need to routinely run ECG for cardiotoxicity in every single patient poisoned by methanol.
- 1 June 2013
- Published by Walter de Gruyter GmbH in Archives of Industrial Hygiene and Toxicology
- Vol. 64 (2) , 265-271
Open AccessElectrocardiographic Manifestations in Acute Methanol Poisoning Cannot Predict Mortality
The aim of this retrospective observational case series was to determine electrocardiographic (ECG) manifestations in patients poisoned with methanol and see whether they could predict mortality. We also wanted to see whether there was an association between ECG changes and time elapsed between ingestion and treatment, age, sex, seizure, coma (Glasgow Coma Scale ≤8), arterial blood gas (ABG) parameters, and serum potassium levels on hospital admission. The study included 42 patients aged 31.14±12.5 years. Twenty-five survived and 17 died. Almost all patients had one or more abnormal ECG findings, including heart rate, rhythm, and conduction abnormalities. However, we found no significant difference between survivors and non-survivors. QTc interval did not correlate with time elapsed between ingestion and treatment, age, sex, seizure and coma, HCO3-, or serum potassium level. Similarly, T waves showed no correlation with serum potassium. ECG abnormalities did not correlate with coma or seizure. Even though cardiotoxicity in methanol poisoning is high, none of the ECG abnormalities found in our study predicted mortality. This however does not rule out the need to routinely run ECG for cardiotoxicity in every single patient poisoned by methanol.
- 1 January 2013
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 31 (1) , 26-31
Tramadol-induced apnea
- 1 January 2013
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 31 (1) , 26-31
Tramadol-induced apnea
- 1 March 2012
- p. 34-7
Tramadol-induced seizures and trauma.
To determine the prevalence, type and site of the injuries due to tramadol-induced seizures in the patients who had referred after its overdose or use of its therapeutic dose. All patients referring to Loghman Hakim Poison Hospital (February 2009 to April 2010) due to tramadol-induced seizures were included. The patients' data including age, gender, ingested dose by history, route of exposure, manner of poisoning, previous history of suicidal attempts, previous history of drug or substance abuse, history of tramadol abuse, type of the seizure, number of episodes of seizure before presentation or after admission, site of the trauma, and type of injury were recorded. A total of 232 patients were included in the study. Of them, 185 (79.7%) had referred within the first 6 hours after ingestion. The mean dose ingested by the history was 1416 +/- 1124 mg. History of tramadol abuse was positive in 114 (49.1%) patients. Seizure episodes had occurred once in 207 (89.2%), twice in 21 (9.1%), and three times in 4 (1.7%) patients. The prevalence of trauma was 24.6% (in 57 patients) with the most frequent site of trauma to the face (9.5%) followed by shoulder (4.3%), head (3%), trunk (1.7%), and upper extremities (1.3%). No statistically significant difference was found between patients with and without trauma associated with tramadol-induced seizures in terms of age, gender, ingested dose by history, positive history of addiction to other opioids, and number of episodes of seizure. The only serious injury associated with this type of seizure was the head injury, present in approximately 1% of the patients.
- 1 March 2012
- p. 34-7
Tramadol-induced seizures and trauma.
To determine the prevalence, type and site of the injuries due to tramadol-induced seizures in the patients who had referred after its overdose or use of its therapeutic dose. All patients referring to Loghman Hakim Poison Hospital (February 2009 to April 2010) due to tramadol-induced seizures were included. The patients' data including age, gender, ingested dose by history, route of exposure, manner of poisoning, previous history of suicidal attempts, previous history of drug or substance abuse, history of tramadol abuse, type of the seizure, number of episodes of seizure before presentation or after admission, site of the trauma, and type of injury were recorded. A total of 232 patients were included in the study. Of them, 185 (79.7%) had referred within the first 6 hours after ingestion. The mean dose ingested by the history was 1416 +/- 1124 mg. History of tramadol abuse was positive in 114 (49.1%) patients. Seizure episodes had occurred once in 207 (89.2%), twice in 21 (9.1%), and three times in 4 (1.7%) patients. The prevalence of trauma was 24.6% (in 57 patients) with the most frequent site of trauma to the face (9.5%) followed by shoulder (4.3%), head (3%), trunk (1.7%), and upper extremities (1.3%). No statistically significant difference was found between patients with and without trauma associated with tramadol-induced seizures in terms of age, gender, ingested dose by history, positive history of addiction to other opioids, and number of episodes of seizure. The only serious injury associated with this type of seizure was the head injury, present in approximately 1% of the patients.
- 1 May 2011
- Published by Elsevier in Medical Hypotheses
- Vol. 76 (5) , 765-766
Is there a role for digoxin in the management of acute aluminum phosphide poisoning?
- 1 May 2011
- Published by Elsevier in Medical Hypotheses
- Vol. 76 (5) , 765-766
Is there a role for digoxin in the management of acute aluminum phosphide poisoning?
- 24 January 2011
- Published by SAGE Publications in Tropical Doctor
- Vol. 41 (2) , 108-110
Clinical features and successful management of suicidal digoxin toxicity without use of digoxin-specific antibody (Fab) fragments – is it possible?
A retrospective study of 147 consecutive cases of suicidal digoxin poisoning was undertaken in order to determine the severity and outcome of toxicity without use of digoxin-specific Fab fragments. This study showed that suicidal digoxin poisoning in young patients is usually mild to moderate; even underlying cardiac disease and chronic use of digoxin has no effect on the severity of toxicity and incidence of lethal dysrhythmia in these cases. This type of toxicity responds appropriately to conventional treatment.
- 24 January 2011
- Published by SAGE Publications in Tropical Doctor
- Vol. 41 (2) , 108-110
Clinical features and successful management of suicidal digoxin toxicity without use of digoxin-specific antibody (Fab) fragments – is it possible?
A retrospective study of 147 consecutive cases of suicidal digoxin poisoning was undertaken in order to determine the severity and outcome of toxicity without use of digoxin-specific Fab fragments. This study showed that suicidal digoxin poisoning in young patients is usually mild to moderate; even underlying cardiac disease and chronic use of digoxin has no effect on the severity of toxicity and incidence of lethal dysrhythmia in these cases. This type of toxicity responds appropriately to conventional treatment.